New SEER data presented at AACR 2025 reveal a sharp decline in breast cancer mortality among women aged 20 to 49 across all ...

Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. ("Arvinas" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...

Olema Pharmaceuticals, Inc.’s OLMA share price has dipped by 5.94%, which has investors questioning if this is right time to buy.

In the face of growing global healthcare challenges, breast cancer remains a key area of ​​concern due to its increasing prevalence worldwide. The Global Breast Cancer Therape ...